Published in Science · View the paper (DOI)
A DNA designer drug restored levels of stathmin-2, a protein necessary for motor neurons to function, in both mouse and human studies. This finding could lead to clinical trials to delay paralysis in ALS patients by maintaining stathmin-2 levels.
Coverage from 2 institutions